LTGO 8-K: Ceo change

Filed with the SEC on Nov 5, 2026 · accession 0001193125-26-448537

LTGO filed a 8-K (current report) with the SEC on Nov 5, 2026. Latigo Biotherapeutics appointed Todd Smith as President and CEO, replacing Nima Farzan, who stepped down from those roles and resigned from the Board effective November 3, 2026. The stock moved -7.3% by the first close after the filing.

Summary of the filing

Latigo Biotherapeutics appointed Todd Smith as President and CEO, replacing Nima Farzan, who stepped down from those roles and resigned from the Board effective November 3, 2026. Farzan will remain as an employee through January 1, 2027 and then as a consultant through December 31, 2027.

For details, click here →How to read a 8-K →

Key details

Todd Smith annualized base salary$775K

Todd Smith annual target performance cash incentive (percentage of base salary)PCT 70

Todd Smith option award grant date fair market value$20.0M

RegistrantLatigo Biotherapeutics, Inc.

President and chief executive officerTodd Smith

Former president, chief executive officer, and board memberNima Farzan

Audit committee memberBeth Seidenberg

Compensation committee memberSara Bonstein

How LTGO stock reacted

Close before

$14.04

Nov 4, 2026

First close after

-7.34%

$13.01

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for LTGO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for LTGO?

Click here

Frequently asked questions

What did LTGO file with the SEC on Nov 5, 2026?

LTGO filed a 8-K (Ceo change). Latigo Biotherapeutics appointed Todd Smith as President and CEO, replacing Nima Farzan, who stepped down from those roles and resigned from the Board effective November 3, 2026. Farzan will remain as an employee through January 1, 2027 and then as a consultant through December 31, 2027.

What does a ceo change mean for LTGO stock?

Not always. A planned retirement with a successor is usually calm; a sudden departure “effective immediately”, especially of a CFO or near results, often worries investors.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

How did LTGO stock react to this filing?

LTGO closed at $14.04 before the filing and $13.01 on Nov 5, 2026 (-7.34%).

Other LTGO SEC filings

10-Q · SEC filingNov 5, 2026

Get alerts when LTGO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

LTGO overview LTGO analysis LTGO news Latest SEC filings